Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Carl Zeiss Meditec AG : achieves strong revenue and EBIT growth in first three months 2018/19

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/15/2019 | 07:37am EDT

Carl Zeiss Meditec (ISIN: DE0005313704) has achieved revenue of approximately EUR 324 million in the first three months of fiscal year 2018/19, based on preliminary data.

This corresponds to revenue growth of around 10% vs. the previous year's value of EUR 294.7 million. Currency effects only had a minor impact on growth.

In the same period, earnings before interest and taxes (EBIT) increased significantly to EUR 48.1 million (prev. year EUR 38.9 million). This corresponds to an EBIT margin (EBIT in percent of revenue) of 14.9% (prev. year 13.2%). EBIT was positively impacted by temporarily reduced research & development expenses. For fiscal year 2018/19, the company still expects an EBIT margin between 14% to 16%.

The 3-months quarterly statement for fiscal year 2018/19 will be published on February 11, 2019.

Contact for investors and press

Sebastian Frericks

Director Investor Relations

Carl Zeiss Meditec AG

Phone: +49 3641 220-116

hinvestors.meditec@zeiss.com

Brief profile

Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on MDAX and TecDax of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery.

With approximately 3,050 employees worldwide, the Group generated revenue of EUR1,280.9m in fiscal year 2017/18 (to 30 September).

The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 41 percent of Carl Zeiss Meditec AG's shares are in free float. The remaining approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.

(C) 2019 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CARL ZEISS MEDITEC AG
08/12CARL ZEISS MEDITEC : continues strong growth trend after nine months of 2018/19
AQ
08/09EUROPE : Italy leads European shares lower on political uncertainty
RE
08/09GLOBAL MARKETS LIVE : Bayer, Huawei, Airbus, Occidental Petroleum…
08/09CARL ZEISS MEDITEC : continues strong growth trend after nine months of 2018/19
EQ
08/02CARL ZEISS MEDITEC AG : Preliminary announcement of the publication of quarterly..
EQ
07/16INFORMATION PURSUANT : Carl Zeiss Meditec is aiming for the upper end of its rev..
PU
07/15CARL ZEISS MEDITEC : is aiming for the upper end of its revenue forecast for the..
EQ
06/19EUROPE : European stocks tread water, all eyes on Fed
RE
06/18A pivotal month of June
06/04A war on all fronts
More news
Financials (EUR)
Sales 2019 1 428 M
EBIT 2019 264 M
Net income 2019 167 M
Finance 2019 659 M
Yield 2019 0,64%
P/E ratio 2019 54,2x
P/E ratio 2020 46,6x
EV / Sales2019 5,84x
EV / Sales2020 5,34x
Capitalization 8 998 M
Chart CARL ZEISS MEDITEC AG
Duration : Period :
Carl Zeiss Meditec AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARL ZEISS MEDITEC AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 85,89  €
Last Close Price 101,90  €
Spread / Highest target -1,86%
Spread / Average Target -15,7%
Spread / Lowest Target -46,0%
EPS Revisions
Managers
NameTitle
Ludwin Monz President & Chief Executive Officer
Michael Kaschke Chairman-Supervisory Board
Justus Felix Wehmer Chief Financial Officer
Markus Guthoff Member-Supervisory Board
Cornelia Grandy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
CARL ZEISS MEDITEC AG47.29%9 979
THERMO FISHER SCIENTIFIC24.90%110 607
DANAHER CORPORATION35.83%100 482
BOSTON SCIENTIFIC CORPORATION20.94%59 201
INTUITIVE SURGICAL3.95%57 377
EDWARDS LIFESCIENCES CORPORATION45.26%46 171